When prescribing Acthar Gel, there is an entire support team available through Mallinckrodt
The Acthar Gel support team includes the Acthar Sales Specialist, the Acthar Reimbursement Manager (ARM), and the Case Manager at the Acthar Hub, a no-cost resource for patients and healthcare professionals.
Acthar Sales Specialists provide clinical and promotional information, including tools and resources to support Acthar Gel treatment. They may provide contact information for other members of the Acthar Gel support team.
ARMs provide dedicated access and reimbursement support to help healthcare professionals work through the reimbursement process. ARMs can provide tools, resources, and patient status updates in person.
Case Managers support patients and healthcare professionals from a central location, the Acthar Hub. Patient support includes helping patients through the reimbursement process, providing information about financial assistance options, scheduling injection training, and coordinating home delivery of Acthar Gel with the Specialty Pharmacy. Support for healthcare professionals includes working with office staff to facilitate the insurance company approval process as well as providing ongoing assistance for patients.
Steps to follow after prescribing Acthar Gel
Complete the Acthar Gel Start Form and fax it to the Acthar Hub at 1-877-937-2284.
The Acthar Hub faxes back a confirmation and contacts the office within 4 business hours to explain next steps, including prior authorization requirements.
The Acthar Hub may contact the office staff with questions. Responding in a timely manner helps ensure patients get Acthar Gel as soon as possible.
Help your eligible patients get 5 free vials* of Acthar Gel with the Commercial Starter Program
The Acthar Gel Ophthalmology Commercial Starter Program* is available for Acthar Gel–naive, commercially or privately insured patients who are prescribed Acthar Gel for an on-label ophthalmic indication. The program is free of charge and allows eligible patients quick access to therapy while you and the Acthar Gel support team work through the reimbursement process. Please see full Terms and Conditions below.
- Therapy-naive commercially or privately insured patients
- Valid on-label prescription for Acthar Gel
- Submit both a Start Form and Commercial Starter Program Form to the Acthar Hub
- Acthar Hub verifies commercial or private insurance
- Commercial Starter Program Form is triaged to Specialty Pharmacy for fulfillment
- Specialty Pharmacy contacts patient to schedule delivery
- Upon receipt of the Start Form and the Commercial Starter Program Form, 1 vial will be shipped to the patient
- Patient will continue to receive 1 vial at a time while the Acthar Hub is working through the benefits verification and approval process
- Provides a maximum of 5 vials per Acthar Gel referral
- Patients may receive up to 3 additional vials if documentation is provided
*Acthar Gel Commercial Starter Program Terms and Conditions
To be eligible, patients need to be Acthar-naive, have a valid Acthar Gel prescription for an FDA-approved, on-label ophthalmic indication, and have verified commercial or private insurance. A patient who is participating in Medicare, Medicaid, or any government-funded healthcare plan is not eligible to participate in the Program. The Program is valid for one vial of Acthar Gel at a time as needed, up to five vials, prior to coverage approval by the patient’s insurance. The patient will no longer receive vials under the Program when the patient receives insurance approval, a final denial of coverage, or the fifth vial. The patient may receive up to an additional three vials if the prescriber provides documentation of need and the patient has not received a final determination from the insurance company. The patient agrees not to seek reimbursement from any third-party payor for all or any part of Acthar Gel dispensed pursuant to the Program. The Program is void where prohibited by law. Mallinckrodt reserves the right to rescind, revoke, or amend the Program at any time without notice. By participating in the Program, the patient agrees to these eligibility terms and conditions.